These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35144031)

  • 1. A Promising Glycolysis- and Immune-Related Prognostic Signature for Glioblastoma.
    Wang F; Liu X; Jiang H; Chen B
    World Neurosurg; 2022 May; 161():e363-e375. PubMed ID: 35144031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Genomic Instability-Associated Prognostic Signature for Glioblastoma Patients.
    Chen X; Tian F; Wu Z
    World Neurosurg; 2022 Nov; 167():e515-e526. PubMed ID: 35977679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
    Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel Foxp3-related immune prognostic signature for glioblastoma multiforme based on immunogenomic profiling.
    Guo XY; Zhang GH; Wang ZN; Duan H; Xie T; Liang L; Cui R; Hu HR; Wu Y; Dong JJ; He ZQ; Mou YG
    Aging (Albany NY); 2021 Jan; 13(3):3501-3517. PubMed ID: 33429364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new prognostic model for glioblastoma multiforme based on coagulation-related genes.
    Zhou M; Deng Y; Fu Y; Liang R; Liu Y; Liao Q
    Transl Cancer Res; 2023 Oct; 12(10):2898-2910. PubMed ID: 37969372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme.
    Yu Z; Yang H; Song K; Fu P; Shen J; Xu M; Xu H
    Front Oncol; 2022; 12():938679. PubMed ID: 35982954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Glucose Metabolism-Related Gene Signature for Overall Survival Prediction in Patients with Glioblastoma.
    Zhang C; Wang M; Ji F; Peng Y; Wang B; Zhao J; Wu J; Zhao H
    Biomed Res Int; 2021; 2021():8872977. PubMed ID: 33553434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and validation of an immune-based prognostic score model in glioblastoma.
    Qin Z; Zhang X; Chen Z; Liu N
    Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma.
    Bi Y; Wu ZH; Cao F
    BMC Cancer; 2022 Mar; 22(1):233. PubMed ID: 35241019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic insights into super-enhancer-driven genes as prognostic signatures in patients with glioblastoma.
    Chen Y; Pan Y; Gao H; Yi Y; Qin S; Ma F; Zhou X; Guan M
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12315-12332. PubMed ID: 37432454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a novel glycolysis-related genes signature for isocitrate dehydrogenase 1-associated glioblastoma multiforme.
    Cai X; Chen Z; Huang C; Shen J; Zeng W; Feng S; Liu Y; Li S; Chen M
    Front Immunol; 2022; 13():950917. PubMed ID: 36389748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel autophagy-related prognostic signature and small molecule drugs for glioblastoma by bioinformatics.
    Wang D; Jiang Y; Wang T; Wang Z; Zou F
    BMC Med Genomics; 2022 May; 15(1):111. PubMed ID: 35550147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel defined risk signature of interferon response genes predicts the prognosis and correlates with immune infiltration in glioblastoma.
    Xiao Y; Wang Z; Zhao M; Ji W; Xiang C; Li T; Wang R; Yang K; Qian C; Tang X; Xiao H; Zou Y; Liu H
    Math Biosci Eng; 2022 Jun; 19(9):9481-9504. PubMed ID: 35942769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma.
    Huang QR; Li JW; Pan XB
    Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of neurotrophic factor-related gene signatures in glioblastoma and Parkinson's disease.
    Zhao S; Chi H; Yang Q; Chen S; Wu C; Lai G; Xu K; Su K; Luo H; Peng G; Xia Z; Cheng C; Lu P
    Front Immunol; 2023; 14():1090040. PubMed ID: 36825022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Hypoxia Prognostic Signature in Glioblastoma Multiforme Based on Bulk and Single-Cell RNA-Seq.
    Ahmed YB; Ababneh OE; Al-Khalili AA; Serhan A; Hatamleh Z; Ghammaz O; Alkhaldi M; Alomari S
    Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of a novel robust glioblastoma prognosis model based on bioinformatics.
    Zhang L; Yan X; Wang Y; Wang Q; Yan H; Yan Y
    Heliyon; 2024 Sep; 10(18):e37374. PubMed ID: 39309926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma.
    Yu W; Ma Y; Hou W; Wang F; Cheng W; Qiu F; Wu P; Zhang G
    Front Immunol; 2021; 12():706936. PubMed ID: 34899682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neutrophil extracellular traps-related gene signature predicts the prognosis of glioblastoma multiforme.
    Sun G; Liu W
    Folia Neuropathol; 2024; 62(1):59-75. PubMed ID: 38174685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Necroptosis-related Molecular Subtypes and Construction of Necroptosis-related Gene Signature for Glioblastoma Multiforme.
    Li Z; Jin Y; Que T; Zhang XA; Yi G; Zheng H; Yuan X; Wang X; Xu H; Nan J; Chen C; Wu Y; Huang G
    Curr Med Chem; 2024; 31(33):5417-5431. PubMed ID: 37539935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.